POLYMORPHISM OF THE CYP2C19 ISOENZYME AS A RISK FACTOR FOR GASTROPATHIES INDUCED BY THE USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH PAIN SYNDROME
No. 3 (2022), Articles
No. 3 (2022)

POLYMORPHISM OF THE CYP2C19 ISOENZYME AS A RISK FACTOR FOR GASTROPATHIES INDUCED BY THE USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH PAIN SYNDROME

Articles
Published 2022-10-03
Lola T. Daminova
Abror Sh. Kasimov
Zafar B. Abdashimov
PDF

Keywords

NSAID, PPIs, Cytochrome P450, gastropathy, gastroduodenal damage

How to Cite

Lola T. Daminova, Abror Sh. Kasimov, & Zafar B. Abdashimov. (2022). POLYMORPHISM OF THE CYP2C19 ISOENZYME AS A RISK FACTOR FOR GASTROPATHIES INDUCED BY THE USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH PAIN SYNDROME. Central Asian Journal of Medicine, (3), 159-166. Retrieved from https://journals.tma.uz/index.php/cajm/article/view/515
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX